Editor in Chief, Journal of Antimicrobial Chemotherapy
Dr Donnelly recently retired from the Radboud University Medical Centre but maintains an active interest in the management and diagnosis of infectious complications associated with haematological malignancies and stem cell transplantation and in the design, conduct, analysis and reporting of clinical trials as well as the definitions, diagnosis, and management of invasive fungal diseases. He has been involved in the Journal of Antimicrobial Chemotherapy for many years and its Editor in Chief since 2015